Immediate Impact

26 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
3 intermediate papers

Works of John F. Bender being referenced

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma
2009
Phase I Study of N1-N11-Diethylnorspermine (DENSPM) Administered TID for 6 Days in Patients with Advanced Malignancies
2001

Author Peers

Author Last Decade Papers Cites
John F. Bender 104 204 40 208 161 22 616
Suguru Imaeda 64 142 4 146 253 26 621
YR Mahida 23 123 13 164 61 24 690
Carolyn A. Brown 36 94 49 160 98 30 739
Giuseppe Belardo 26 107 5 275 166 13 646
H. Weiler 27 72 5 140 161 29 731
Herman Mattie 62 82 10 133 284 22 663
T Murayama 22 56 1 126 177 24 563
Ae‐Ran Choi 44 139 9 178 87 33 549
Célia R. Whitaker Carneiro 26 75 6 284 119 30 614
Walter Miguel Turato 27 51 4 180 259 34 643

All Works

Loading papers...

Rankless by CCL
2026